What is it about?
Pharmacogenomics is the study of genetic variation and its association with variability in an individual's response to medications. This editorial discusses the state of the field as applied to kidney disease.
Featured Image
Read the Original
This page is a summary of: The Potential of Pharmacogenomics to Advance Kidney Disease Treatment, Clinical Journal of the American Society of Nephrology, June 2017, American Society of Nephrology,
DOI: 10.2215/cjn.05170517.
You can read the full text:
Contributors
The following have contributed to this page
